Abstract. The 
and aldosterone before, during and after a 5 h infusion of metyrapone ditartrate at doses of 0.2 g/h and 0.8 g/h respectively. Time courses of plasma steroids and corticotrophin indicate an inhibitory effect of metyrapone on total adrenal steroidogenesis in addition to the known inhibition of the 11-and 18-monooxygenase. The (Liddle et al. 1959; Strottetal. 1969; Spark 1971; Mahajanetal. 1972; Spiger et al. 1975; Sakamoto et al. 1976 ; Leisti 1977; Best et al. 1980; Feek et al. 1981 ).
Meanwhile, data have been published indicating additonal inhibitory effects of metyrapone on adrenal enzymes other than 11-monooxygenase. Inhibition of 18-monooxygenase has been shown under in vitro (Erickson et al. 1966 ) and in vivo conditions (Schöneshöfer et al. 1980 (Schneider 1964 (Schöneshöfer et al. 1981a ). Sensitivity of the method was 1.47 ± 0.29 pmol/1. After extraction from 1 ml of plasma and effective fractionation by high performance liquid chromatography, plasma steroids were estimated by radioimmunoassay. The protocol and analytical assay parameters have been detailed in an analytical paper (Schöneshöfer et al. 1981b ).
Statistic comparisons of mean values were performed by Student's i-test. (Fig. 3 Ab and 3 Bb). In the high-dose experiment, however, plasma S even further increased reaching a maximum at 3 p.m. (Fig. 3 Ac) and plasma DOC remained elevated up to 2 p.m. (Fig. 3 Be).
Responses ofplasma corticosterone and cortisol The mean concentrations of plasma and F fell consistently throughout the infusion period ( Fig. 3 C and D) (Fig. 4 A) . The strong fluctuations of plasma concentrations were partially caused by analytical insufficiency since plasma concentrations were scattering around the detection limit of the analytical method. In both metyrapone experi¬ ment, changes of plasma 18-OH-B and Aldo were characterized by more or less consistent falls during the experiment (Fig. 4 and 4 C ). There were no reincreases discernible during the rest of the experiment.
Responses of the sum of all steroids measured In the early phase of the metyrapone infusion period, the sum of all steroids measured consistent¬ ly fell in both metyrapone experiments (Fig. 4 Db and c). In the low-dose experiment, the further time course of the cumulative steroid concentra¬ tion (Fig. 4 Db) approximately followed the kine¬ tics of plasma ACTH (Fig. 1 b) . There were no significant differences if compared with the cor¬ responding data of the control experiment (Fig. 4 In most of the previous experiments on effects of metyrapone on steroidogenesis, high doses of metyrapone had been administered orally (Sawano et al. 1972; Schöneshöfer et al. 1980; Matsuki et al. 1982 Changes of plasma 18-OH-11-deoxycorticosterone (A), 18-OH-corticosterone (B), aldosterone (C), and of the sum of all steroids measured (D) during the control (a), the low-dose (b) and the high-dose experiment (c (Fig. 4 D) (Levin et al. 1978 (Schneider 1964) . It obviously be¬ comes negligible when metyrapone concentrations are lowered to levels sufficient for 11-monooxygenase blockade but insufficient for 'inhibition' of total adrenal steroidogenesis. Considering in addition the lowering effect of metyrapone on plasma ACTH (Fig. 1) Leisti (1977) .
